Clik here to view.
SpeeDxとMolGenがCOVID-19検査ソリューションでの提携を発表
シドニー & 蘭ユトレヒト （ビジネスワイヤ） — SpeeDx Pty, Ltd.とMolGenは、欧州およびアジア太平洋地域における臨床診断製品／機器の供給・流通で連携する提携契約を締結したと発表しました。本提携により、検体ハンドリング、核酸抽出、アッセイセットアップ、増幅、検査結果報告を、両社の技術のシームレスな統合という形で結び付けます。...
View ArticleClik here to view.
SpeeDx和MolGen宣布合作开发新冠病毒检测解决方案
悉尼和荷兰乌特勒支 (美国商业资讯)–SpeeDx Pty, Ltd.和MolGen宣布签署一份协议，合作开展临床诊断产品和仪器在欧洲和亚太区的供应和分销。通过此次合作，可贯通样本处理、核酸提取、检测设置、扩增和结果报告流程，实现两家公司技术的无缝整合。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
PHC株式会社：最先端のゲノム医療研究への貢献を目指した、次世代シーケンサー「DNBSEQ™シリーズ」を発売
東京 （ビジネスワイヤ） — PHC株式会社（本社：東京都港区、代表取締役社長：森本 恭史、以下「PHC」）は、このたび、MGI Tech Co., Ltd.（本社：中華人民共和国深セン市、代表取締役社長：牟...
View ArticleClik here to view.
Biocept Receives South Korean Patent for Primer-Switch Platform Used to...
SAN DIEGO Biocept, Inc. (NASDAQ: BIOC), a leading provider of molecular diagnostic assays and services, has been awarded a South Korean Patent for its Primer-Switch technology, which detects rare...
View ArticleClik here to view.
Affinivax and Astellas Present Safety and Immunogenicity Data from Phase 2...
CAMBRIDGE, Mass. & TOKYO Affinivax, Inc. (“Affinivax”) and Astellas Pharma Inc. (“Astellas”) announced results from the Phase 2 clinical trial of ASP3772, a novel vaccine candidate targeting...
View ArticleClik here to view.
Aragen Announces Partnership with Skyhawk Therapeutics, Aimed at Developing...
HYDERABAD, India Aragen Life Sciences (formerly, GVK BIO), a leading Contract Research and Development Organization (CRDO), headquartered out of Hyderabad, India, announced that it has been selected...
View ArticleClik here to view.
CANbridge Pharmaceuticals CAN106 Investigational New Drug Application...
BEIJING & CAMBRIDGE, Mass. CANbridge Pharmaceuticals Inc., a leading China-based global rare disease-focused biopharmaceutical company committed to the research, development and...
View ArticleClik here to view.
Regencell Bioscience Holdings Limited Announces Pricing of Approximately...
HONG KONG Regencell Bioscience Holdings Limited (NASDAQ:RGC) (“Regencell” or the “Company”), an early-stage bioscience company that focuses on research, development and commercialization of...
View ArticleClik here to view.
Kyowa Kirin Announces EU Approval for the Self-administration of CRYSVITA® ▼...
TOKYO Kyowa Kirin Co., Ltd. (TSE:4151, Kyowa Kirin) today announced that CRYSVITA® (burosumab) has been approved for the option of self-administration in the European Union (EU) for the treatment of...
View ArticleClik here to view.
Regencell Bioscience Holdings Limited、2190万ドル規模の新規株式公開を実施
香港 （ビジネスワイヤ） — 神経認知障害および変性症治療（特に注意欠陥・多動性障害（ADHD）と自閉症スペクトラム障害（ASD））のための中国漢方薬（TCM）の研究・開発・商業化に取り組む早期段階のバイオサイエンス企業Regencell Bioscience Holdings...
View ArticleClik here to view.
Moderna Partners with Takeda and the Government of Japan to Supply Additional...
CAMBRIDGE, Mass. Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the Ministry of Health, Labour and Welfare of...
View ArticleClik here to view.
Regencell Bioscience Holdings Limited宣布约2,190万美元的首次公开发行定价
香港 (美国商业资讯)–Regencell Bioscience Holdings...
View ArticleClik here to view.
Regencell Bioscience Holdings Limited Announces Closing of Initial Public...
HONG KONG Regencell Bioscience Holdings Limited (NASDAQ:RGC) (“Regencell” or the “Company”), an early-stage bioscience company that focuses on research, development and commercialization of...
View ArticleClik here to view.
Aurion Biotech Announces IOTA Cell Therapy Trial
SEATTLE & BOSTON & TOKYO Aurion Biotech, whose mission is to cure blindness by developing a differentiated platform of advanced therapies to treat ocular diseases, today announced...
View ArticleClik here to view.
Twist Bioscience Incorporates MOLCURE AI Technology to Augment Therapeutic...
SOUTH SAN FRANCISCO, Calif. & KAWASAKI, Japan Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its...
View ArticleClik here to view.
Twist Bioscience社がMOLCURE社の人工知能技術を導入し、抗体医薬品の探索を強化
米国カリフォルニア州サウス ビジネスワイヤ） — サンフランシスコと日本川崎 – 半導体プラットフォームを用いた高品質な合成DNAを提供し、顧客の成功を支援しているTwist Bioscience社（Nasdaq:...
View ArticleClik here to view.
ERS Genomicsと日本エスエルシーがCRISPR/Cas9ライセンス契約に署名
DUBLIN & SHIZUOKA, Japan （ビジネスワイヤ） –ERS Genomics...
View ArticleClik here to view.
Deargen Signs Agreement With Sookmyung Women’s University Research & Business...
SEOUL, South Korea Deargen (President: Kilsoo Kang), an artificial intelligence (AI)-powered drug discovery and development company, announced on July 27 that it signed an agreement with Sookmyung...
View ArticleClik here to view.
U.S. Food and Drug Administration Grants Breakthrough Therapy Designation to...
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy...
View ArticleClik here to view.
FDA Clears Promega OncoMate™ MSI Dx Analysis System
MADISON, Wis. Oncologists and pathologists in the United States can now access a new in vitro diagnostic (IVD) test that screens for Lynch syndrome in patients with colorectal cancer. The OncoMate™...
View Article